I-Doct Pharma Private Limited
About I-Doct Pharma Private Limited
Data last updated:
I-Doct Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 13 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2015PTC262698. Its GSTIN is 27AADCI7708K1Z9 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dilip Parimal Biswas and Pradip Parimal Biswas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 131 132 132/A First Floor House No. 2053 Ward No. 5 Chaturbhuj Jain Layout Wadi, Nagpur, Maharashtra, India – 440023.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.3 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹62,477 (net margin 1.2%) and EBITDA of ₹2.45 Lakh (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 1% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
I-Doct Pharma Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 131 132 132/A First Floor House No. 2053 Ward No. 5 Chaturbhuj Jain Layout Wadi, Nagpur, Maharashtra, India – 440023
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of I-Doct Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of I-Doct Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of I-Doct Pharma Private Limited, buy the company report.
Financials of I-Doct Pharma Private Limited
FY 2025 filings availableI-Doct Pharma Private Limited reported revenue of ₹54.3 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 3% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.45 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹62,477 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of I-Doct Pharma Private Limited, buy the company report.
Board of directors of I-Doct Pharma Private Limited
I-Doct Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dilip Parimal Biswas | Director | 13 Mar 2015 | 11 Years 7 Months | Current |
| Pradip Parimal Biswas | Director | 13 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
I-Doct Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mayom Biotechnology Private Limited | ₹54.6 Lakh (FY 2025) | 1.0% | Thane, Maharashtra, India | |||
| Puranjay Infosol Private Limited | ₹54.52 Lakh (FY 2024) | Kolkata, West Bengal, India | ||||
| PNR Agro Agencies Private Limited | ₹54.4 Lakh (FY 2025) | -16.0% | Vijayawada, Andhra Pradesh, India | |||
| Aayuvardhanam Private Limited | ₹54.36 Lakh (FY 2025) | 38.0% | Karad, Maharashtra, India | |||
| Patwariji Agencies Private Limited | ₹54.32 Lakh (FY 2025) | -25.0% | New Delhi, Delhi, India | |||
| I-Doct Pharma Private Limitedthis company | ₹54.3 Lakh (FY 2025) | ₹62,477 | 1.2% | 3.0% | Nagpur, Maharashtra, India | |
| Goldstar Nutrition Private Limited | ₹54.17 Lakh (FY 2025) | -6.0% | Howrah, West Bengal, India | |||
| Ergonomic Accessories Commerce Private Limited | ₹53.88 Lakh (FY 2025) | -9.0% | Pune, Maharashtra, India | |||
| Sol Lifestyle Private Limited | ₹53.84 Lakh (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Mym Infrastructure and Services Private Limited | ₹53.68 Lakh (FY 2025) | 174.0% | Mumbai, Maharashtra, India | |||
| Jes & Ben Groupo Private Limited | ₹53.59 Lakh (FY 2025) | -81.0% | New Delhi, Delhi, India |
To see the full peer comparison of I-Doct Pharma Private Limited, buy the company report.
Auditor
I-Doct Pharma Private Limited is audited by NIRAJ NIMJE & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NIRAJ NIMJE & ASSOCIATES | FY 2017 | 124550W |
Shareholding
The shareholding of I-Doct Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of I-Doct Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving I-Doct Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for I-Doct Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
I-Doct Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCI7708K1Z9 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of I-Doct Pharma Private Limited, buy the company report.
Recent activity
I-Doct Pharma Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Dilip Parimal Biswas was appointed as Director on 13 Mar 2015.
Frequently asked questions
I-Doct Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 13 March 2015 (11+ years old) and is registered under CIN U74999MH2015PTC262698.
I-Doct Pharma has 2 current directors:
- Dilip Parimal Biswas - Director
- Pradip Parimal Biswas - Director
The latest financial statements of I-Doct Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of I-Doct Pharma is 27AADCI7708K1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of I-Doct Pharma is U74999MH2015PTC262698. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
I-Doct Pharma was incorporated on 13 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of I-Doct Pharma by revenue are Mayom Biotechnology Private Limited, Puranjay Infosol Private Limited, PNR Agro Agencies Private Limited, Aayuvardhanam Private Limited, Patwariji Agencies Private Limited and 5 more, all in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles).
Dilip Parimal Biswas was appointed as Director on 13 Mar 2015. Pradip Parimal Biswas was appointed as Director on 13 Mar 2015.
The registered office of I-Doct Pharma is at Plot No. 131 132 132A First Floor House No. 2053 Ward No. 5 Chaturbhuj Jain Layout Wadi, Nagpur, Maharashtra, India – 440023.
I-Doct Pharma operates in the trading industry, in the other wholesale segment.
The compliance status of I-Doct Pharma is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.